High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

So what are Ozempic burps, exactly? Read on for the full scoop from a medical expert , plus some sage advice on how best to ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Senator Bernie Sanders reveals that generic drug manufacturers can sell semaglutide, the generic of Ozempic & Wegovy, for less than $100 a month.

The active ingredient in Wegovy goes by the chemical name semaglutide. The first place an expiring patent will allow generic ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Semaglutide is a generic medication. Its brand names are approved for the treatment of type 2 diabetes and obesity. Compounded semaglutide is not FDA-approved, could come with risks, and may lead ...

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...

Swiss pharmaceutical company Sandoz is launching a generic semaglutide, the main ingredient of Ozempic, in the U.S. when the market opens in 2030, Bloomberg reported Sept. 3. The company first ...

We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...